Annual Total Liabilities
$14.65 M
+$4.16 M+39.73%
December 31, 2024
Summary
- As of March 13, 2025, MLYS annual total liabilities is $14.65 million, with the most recent change of +$4.16 million (+39.73%) on December 31, 2024.
- During the last 3 years, MLYS annual total liabilities has fallen by -$19.40 million (-56.99%).
- MLYS annual total liabilities is now -91.21% below its all-time high of $166.71 million, reached on December 31, 2022.
Performance
MLYS Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$14.65 M
-$16.68 M-53.24%
December 31, 2024
Summary
- As of March 13, 2025, MLYS quarterly total liabilities is $14.65 million, with the most recent change of -$16.68 million (-53.24%) on December 31, 2024.
- Over the past year, MLYS quarterly total liabilities has increased by +$4.16 million (+39.73%).
- MLYS quarterly total liabilities is now -91.21% below its all-time high of $166.71 million, reached on December 31, 2022.
Performance
MLYS Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
MLYS Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +39.7% | +39.7% |
| 3 y3 years | -57.0% | +39.7% |
| 5 y5 years | +188.1% | +39.7% |
MLYS Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -91.2% | +39.7% | -91.2% | +136.0% |
| 5 y | 5-year | -91.2% | +188.1% | -91.2% | +136.0% |
| alltime | all time | -91.2% | +188.1% | -91.2% | +136.0% |
Mineralys Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $14.65 M(+39.7%) | $14.65 M(-53.2%) |
| Sep 2024 | - | $31.32 M(+10.3%) |
| Jun 2024 | - | $28.40 M(+47.9%) |
| Mar 2024 | - | $19.20 M(+83.2%) |
| Dec 2023 | $10.48 M | $10.48 M(-22.6%) |
| Sep 2023 | - | $13.54 M(+118.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $6.21 M(-41.2%) |
| Mar 2023 | - | $10.56 M(-93.7%) |
| Dec 2022 | $166.71 M(+389.6%) | $166.71 M(+0.5%) |
| Sep 2022 | - | $165.86 M(+387.1%) |
| Dec 2021 | $34.05 M(+569.9%) | - |
| Dec 2021 | - | $34.05 M |
| Dec 2020 | $5.08 M | - |
FAQ
- What is Mineralys Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Mineralys Therapeutics?
- What is Mineralys Therapeutics annual total liabilities year-on-year change?
- What is Mineralys Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Mineralys Therapeutics?
- What is Mineralys Therapeutics quarterly total liabilities year-on-year change?
What is Mineralys Therapeutics annual total liabilities?
The current annual total liabilities of MLYS is $14.65 M
What is the all time high annual total liabilities for Mineralys Therapeutics?
Mineralys Therapeutics all-time high annual total liabilities is $166.71 M
What is Mineralys Therapeutics annual total liabilities year-on-year change?
Over the past year, MLYS annual total liabilities has changed by +$4.16 M (+39.73%)
What is Mineralys Therapeutics quarterly total liabilities?
The current quarterly total liabilities of MLYS is $14.65 M
What is the all time high quarterly total liabilities for Mineralys Therapeutics?
Mineralys Therapeutics all-time high quarterly total liabilities is $166.71 M
What is Mineralys Therapeutics quarterly total liabilities year-on-year change?
Over the past year, MLYS quarterly total liabilities has changed by +$4.16 M (+39.73%)